# Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin

> **NCT01340235** · PHASE3 · UNKNOWN · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 8 (estimated)

## Conditions studied

- Epidermolysis Bullosa

## Interventions

- **DRUG:** Oral erythromycin

## Key facts

- **NCT ID:** NCT01340235
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2011-12
- **Final completion:** 2012-06
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2011-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01340235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01340235, "Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01340235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*